Coronary Artery Bypass Surgery News and Research

RSS

Coronary Artery Bypass is surgery in which a healthy blood vessel taken from another part of the body is used to make a new path for blood around a blocked artery leading to the heart. This restores the flow of oxygen and nutrients to the heart. Also called aortocoronary bypass and CAB.

Delaying elective coronary artery bypass graft surgery: post-operative death risks

Delaying elective coronary artery bypass graft (CABG) surgery may be a significant risk factor for post-operative death. Research published today in the open access journal BMC Health Services Research reveals that when patients received timely surgery, the risk of death was reduced by a third.

21 Sep 2008

Results from the Simvastatin and Ezetimibe in aortic stenosis study

The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has investigated the effects of intensive cholesterol lowering with the combination of simvastatin (40 mg daily) and ezetimibe (10 mg daily) in patients with aortic stenosis.

2 Sep 2008

Researchers say heart bypass a better option than drug-eluting stents

Major clinical research has found that for many patients with clogged arteries, bypass surgery is a better option than drug-eluting stents.

2 Sep 2008

Who needs cardiac surgery?

Throughout the developed world, cardiac surgery faces increasing challenges from percutaneous intervention, currently with revascularisation, but potentially soon for valve replacement as well. The spectacular growth of PCI in the UK over the last five years is typical for many developed countries.

31 Aug 2008

DES in diabetic patients

The issue of using or not using DES in patients with diabetes will be debated between Professor Wijns, who discourages DES and Professor Silber, who feels that they should be used.

31 Aug 2008

Ultrasound imaging predicts heart attack risk

Repeat exams using widely available and inexpensive ultrasound imaging could help identify patients at high risk for a heart attack or other adverse cardiovascular events, according to a study published in the September issue of the journal Radiology.

19 Aug 2008

Drug-releasing coronary artery stent use linked with decrease in procedures to unblock coronary arteries

The widespread adoption of the use of drug-releasing coronary artery stents into routine practice is associated with a decrease in the need for repeat procedures to unblock coronary arteries and also do not appear to increase the risk of death, compared to bare-metal stents, according to a study in the June 25 issue of JAMA, the Journal of the American Medical Association

24 Jun 2008

New evidence-based blood clot guidelines for pregnant women

New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies.

24 Jun 2008

Beta blockers after surgery more risky than beneficial

The results of new research has shown that patients given high doses of beta blocker drugs following non-cardiac surgery were more likely to have a stroke or die. However they were less likely to suffer a heart attack.

13 May 2008

Minimally invasive heart bypass surgery using a DaVinci robot provides health and economic benefits

Minimally invasive heart bypass surgery using a DaVinci robot means a shorter hospital stay and faster recovery for patients, as well as fewer complications and a better chance that the new bypass vessels will stay open.

27 Apr 2008

Number of general surgeons in U.S. declined by 26% since 1981

The ratio of practicing general surgeons to patients in the U.S. declined by 26% between 1981 and 2005, according to an analysis published Monday in the Archives of Surgery, Reuters reports.

22 Apr 2008

Rates of death following coronary artery bypass graft surgery decline since 1997

Rates of death following coronary artery bypass graft (CABG) surgery have declined since 1997 while the number of procedures performed has decreased, according to a report in the April issue of Archives of Surgery.

21 Apr 2008

Patients arriving at hospitals in daytime hours get faster, better care compared to off hours

Patients hospitalized with heart attacks tend to get faster and more comprehensive care if they arrive during daytime hours, according to a report in Circulation: Journal of the American Heart Association.

21 Apr 2008

Minimally invasive, robotically-assisted coronary artery bypass graft surgery

Dr. Robert Poston is a pioneer in the use of robotics for minimally invasive cardiac surgery.

8 Apr 2008

Malfunctioning kidneys may raise risk of sudden death in women

Women whose kidneys are poor at filtering impurities from the blood are at heightened risk of sudden cardiac death, according to a report published in Hypertension: Journal of the American Heart Association.

8 Apr 2008

Life after coronary bypass surgery

For many years, assumptions have lingered that Coronary Artery Bypass Surgery Grafting (CABG) produces measurable cognitive impairment, either because of the surgery or use of cardiopulmonary bypass.

4 Apr 2008

Drug does not appear to reduce risk of heart attack or death following CABG surgery

Use of MC-1 (a naturally occurring metabolite of vitamin B6) before and for 30 days after coronary artery bypass graft surgery did not reduce the risk of heart attack or cardiovascular death, according to a JAMA study being released early online April 1 to coincide with its presentation at the annual conference of the American College of Cardiology.

2 Apr 2008

Study confirms aprotinin drug increases cardiac surgery death rate

The largest study to date of a controversial cardiac surgery drug shows it increases death rates and damages kidney function, according Duke University Medical Center researchers.

21 Feb 2008

Daiichi Sankyo, Lilly submit NDA for investigational antiplatelet drug, Prasugrelin U.S.

Daiichi Sankyo Company, Limited and Eli Lilly and Company have announced that on Wednesday, Dec. 26, 2007, they submitted a New Drug Application (NDA) for prasugrel to the U.S. Food and Drug Administration (FDA).

7 Jan 2008

FDA committees recommend continued U.S. marketing for Trasylol

The Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) held a meeting to discuss the risk /benefit profile of Trasylol (aprotinin injection), a Bayer drug used in coronary artery bypass graft (CABG) surgery.

13 Sep 2007